Pregnancy-Associated Plasma Protein-A Levels and Coronary Angiographic Features in Acute Coronary Syndrome Patients

Abstract EN

Background.

Pregnancy-associated plasma protein-A (PAPP-A) is a biomarker of plaque rupture, associated with adverse cardiac events in acute coronary syndromes (ACSs) patients.

Aim.

To identify coronary angiographic (CA) features related to PAPP-A level elevation in ACSs patients.

Methods.

Forty ACSs patients were enrolled in this prospective cohort study (level of evidence: III-prognostic).

Serum samples for PAPP-A quantitation were obtained upon coronary care unit admission.

All patients underwent CA and coronary intervention within 6 hours of sampling.

Results.

Mean age of the study cohort was 57 ± 11 years, (males: 55%, n=22).

Patients with ST-segment elevation myocardial infarction (35%, n=14) showed significantly higher serum PAPP-A level (11.8 ± 2 µg/mL), compared to non-ST-segment elevation myocardial infarction (15%, n=6) and unstable angina (50%, n=20) patients (11 ± 2.6 µg/mL and 8.7 ± 2.3 µg/mL, resp., P<0.001).

Higher PAPP-A levels were significantly associated with complex culprit lesion morphology (11.8 ± 2 µg/mL for type C lesions, 9.7± 2.5 µg/mL and 7.3 ± 3.5 µg/mL for type B and type A lesions, resp., P<0.001), while no relationship to number of diseased coronaries.

Conclusion.

Higher PAPP-A levels in ACSs patients are associated with unfavorable coronary anatomy and complex angiographic plaque features.